Offer - Urjas Oil for just ₹ 1 X
Thycad 50 Capsule is a prescription drug, available for use as Capsule. Primarily, it is used for the treatment of Multiple Myeloma. Secondary and off-label uses of Thycad 50 Capsule have also been mentioned below.
The optimal dosage of Thycad 50 Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Thycad 50 Capsule side effects, there are can be others also. These have been listed below. Usually, these side effects of Thycad 50 Capsule go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Thycad 50 Capsule has a Severe effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Thycad 50 Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Thycad 50 Capsule related warnings section.
Thycad 50 Capsule is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bleeding, Gastrointestinal Bleeding are examples of such conditions. Other conditions have been mentioned below in the Thycad 50 Capsule contraindications section.
Besides this, Thycad 50 Capsule may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Thycad 50 Capsule is not safe while driving, and is not addiction.
Thycad 50 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Thycad 50 Capsule safe for pregnant women?
Thycad can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Thycad 50 Capsule safe during breastfeeding?
There is no research available on the side effects of Thycad in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Thycad 50 Capsule on the Kidneys?
Thycad rarely affects the kidneys.
What is the effect of Thycad 50 Capsule on the Liver?
Very few cases of side effects of Thycad on the liver have been reported.
What is the effect of Thycad 50 Capsule on the Heart?
There may be an adverse effect on the heart after taking Thycad. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Thycad 50 Capsule unless your doctor advises you to do so -
Is this Thycad 50 Capsule habit forming or addictive?
Thycad 50 Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Thycad 50 Capsule. So it is best to avoid driving.
Is it safe?
Yes, Thycad 50 Capsule is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Thycad 50 Capsule for mental disorders.
Interaction between Food and Thycad 50 Capsule
Due to the absence of research, it is difficult to say how Thycad 50 Capsule and food will interact.
Interaction between Alcohol and Thycad 50 Capsule
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Thycad 50 Capsule.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalomid® (thalidomide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 786
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1195-1198